Table 2.
Participant characteristics
| Total | |
|---|---|
| Gender n (%) | |
| Female | 19 (57.6) |
| Male | 14 (42.4) |
| Age M (SD) | 80.18 (8.27) |
| Marital status n (%) | |
| Married | 14 (42.4) |
| Widowed | 17 (51.5) |
| Divorced | 2 (6.1) |
| Residing n (%) | |
| Community | 30 (90.9) |
| Residential Facility | 3 (9.2) |
| Ethnicity n (%) | |
| White (British) | 28 (84.8) |
| White (other) | 2 (6.1) |
| Black | 1 (3) |
| Asian | 2 (6.1) |
| Dementia diagnosis n (%) | |
| Alzheimer’s Disease | 13 (39.4) |
| Vascular Dementia | 5 (15.2) |
| Dementia of mixed etiology | 7 (21.2) |
| Unknown sub-type | 8 (24.2) |
| Time since diagnosis n (%) | |
| < 1 year | 8 (24.2) |
| 1– 2 years | 3 (9.1) |
| 2– 3 years | 8 (24.2) |
| > 3 years | 6 (18.2) |
| Unknown | 8 (24.2) |
| Cholinesterase inhibitors n (%) | |
| None | 17 (51.5) |
| Donepezil | 4 (12.1) |
| Memantine | 6 (18.2) |
| Rivastigmine | 3 (9.1) |
| Galantamine | 2 (6.1) |
| Donepezil and Memantine | 1 (3) |
| Other psychotropic medication n (%) | |
| None | 27 (81.8) |
| Anti-depressant | 6 (18.2) |